ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q2 2022 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2022-08-15

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $28.35M (100.0% shares, 0.0% debt)

Holdings (3)

— MEDAVAIL HOLDINGS INC 81.1%

Value $23M Shares 15,029,480 Est. Cost $5.03 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 15.8%

Value $4.465M Shares 1,038,296 Est. Cost $7.36 Unrealized -36.8%

LUNG PULMONX CORP 3.1%

Value $886K Shares 60,204 Est. Cost $48.97 Unrealized -57.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MEDAVAIL HOLDINGS INC	15,029,480	$23M	81.1%	$5.03	—	COM	58406B103
RPID	RAPID MICRO BIOSYSTEMS INC	1,038,296	$4.465M	15.8%	$7.36	-36.8%	CLASS A COM	75340L104
LUNG	PULMONX CORP	60,204	$886K	3.1%	$48.97	-57.9%	COM	745848101